Cardiovascular Effects of 1,5-Benzothiazepine Derivatives Having a l-cis and d-cis Configuration in Anesthetized Dogs
スポンサーリンク
概要
- 論文の詳細を見る
TA-993,a new 1,5-benzothiazepine derivative having a l-cis configuation, has a selective increasing action on limb blood flow, in addition to an antiplatelet aggregating action. The cardiovascular action of TA-993 is quite different from diltiazem, which is a well-known 1,5-benzothiazepine derivative having a d-cis configuration.Therefore, we compared the cardiovascular actions of d-cis and l-cis isomers of TA-993 with those of diltiazem. l-cis-Diltiazem, as well as TA-993,progressively increased femoral, brachial and common carotid blood flow with little change in arterial pressure or vertebral blood flow. However, the peak response to l-cis-diltiazem (20 min after the administration) was observed earlier than that to TA-993 (60 min after the administration). On the other hand, d-cis-TA-993,as well as diltiazem, caused transient hypotension, tachycardia and increases in vertebral, brachial, femoral and common carotid blood flow. Furthermore, their peak effects were observed immediately after the administration. Potency ratios of the vasorelaxing effects of TA-993,l-cis-diltiazem and d-cis-TA-993 to diltiazem in the isolated and K^+-contracted canine femoral artery were 0.096,0.032 and 1.209,respectively. pA_2 values for TA-993 and diltiazem against Ca^<2+>-induced contractions in the isolated and K^+-depolarized canine saphenous artery were 5.50±0.11 and 7.12±0.18,respectively. These results indicate that TA-993 shares a common profile with l-cis-diltiazem, and suggest that 1,5-benzothiazepine derivatives of a l-cis configuration are a different class of drug from that of the d-cis configuration.
- 公益社団法人日本薬学会の論文
- 1998-01-15
著者
-
Narita H
Toyama Chemical Co. Ltd. Toyama Jpn
-
NARITA Hiroshi
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
KABURAKI Minako
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
DOI Hisayoshi
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Yasuhara Mikiko
Pharmaceutical Development Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Doi Hisayoshi
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd
-
Inoue Hirotaka
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Narita H
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd
-
INOUE Hirotaka
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.,
-
Kaburaki Minako
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd
関連論文
- Antithrombotic Effect of TA-993, a Novel 1,5-Benzothiazepine Derivative, in Conscious Rats
- Comparison of the Sympathetic Nervous System Activity between Spontaneously Hypertensive and Wistar-Kyoto Rats to Respond to Blood Pressure Reduction
- Acute and Chronic Effects of T-1032, a Novel Selective Phosphodiesterase Type 5 Inhibitor, on Monocrotaline-Induced Pulmonary Hypertension in Rats
- Possible Therapeutic Effect of T-794,a Novel Reversible Inhibitor of Monoamine Oxidase-A, on Post-Stroke Emotional Disturbances, Assessed in Animal Models of Depression
- Cardiovascular Effects of 1,5-Benzothiazepine Derivatives Having a l-cis and d-cis Configuration in Anesthetized Dogs
- Protective Effect of TA-993, a Novel Therapeutic Agent for Peripheral Circulatory Insufficiency, on Skeletal Muscle Fatigue in a Rat Model of Hindlimb Ischemia
- Pharmacological Properties of T-3762,a Novel Fluoroquinolone Antimicrobial Agent in Parenteral Use. III. Chemical Structures and Dermovascular Permeability-Increasing Activities
- Histamine-Releasing Properties of T-3762,a Novel Fluoroquinolone Antimicrobial Agent in Intravenous Use. II. Dermovascular Permeability-Increasing Effect and Action on Peritoneal Mast Cells
- Histamine-Releasing Properties of T-3762,a Novel Fluoroquinolone Antimicrobial Agent in Intravenous Use. I. Effects of Doses and infusion Rate on Blood Pressure, Heart Rate and Plasma Histamine Concentration
- Prolongation of the Life Span of Cardiomyopathic Hamster by the Adrenergic β_1 : Selective Partial Agonist Denopamine
- PHARMACOLOGICAL EFFECTS OF NICERGOLINE AND ITS METABOLITES, DECOMPOSITION PRODUCTS AND IMPURITIES IN ANIMALS
- HYPOTENSIVE ACTION OF DILTIAZEM IN CONSCIOUS RENAL HYPERTENSIVE DOGS : COMPARISON WITH NIFEDIPINE AND INTERACTION WITH PINDOLOL
- HYPOTENSIVE RESPONSE OF SPONTANEOUSLY HYPERTENSIVE RATS TO CENTRALLY ADMINISTERED DILTIAZEM AND ITS METABOLITES : IN RELEVANCE TO THE HYPOTENSIVE ACTION BY ORAL ADMINISTRATION
- A Novel Angiotensin II-Receptor Antagonist, 606A, Induces Regression of Cardiac Hypertrophy, Augments Endothelium-Dependent Relaxation and Improves Renal Function in Stroke-Prone Spontaneously Hypertensive Rats
- Cardioprotective Effects of an Angiotensin-Converting-Enzyme Inhibitor,Imidapril, and Ca2+ Channel Antagonist, Amlodipine, in Spontaneously Hypertensive Rats at Established Stage of Hypertension
- Ischemia-Reperfusion Induced Elevation of Diastolic Tension in the Isolated Guinea Pig Heart and the Effects of Calcium Antagonists
- Reduction of the Mortality Rate by Imidapril in a Small Coronary Artery Disease Model, (NZW*BXSB)F1 Male Mice.